Patents by Inventor Ann W. Funkhouser

Ann W. Funkhouser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hepatitus A virus vaccines
    Patent number: 6680060
    Abstract: A live hepatitis A virus adapted to growth in MRC-5 cells, which HAV is preferably characterized by suitable attenuation for effective vaccine administration to humans and animals without inactivation, methods for adapting HAV to growth in MRC-5, vaccine compositions and method of vaccinating humans against HAV infection.
    Type: Grant
    Filed: April 29, 2002
    Date of Patent: January 20, 2004
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Ann W. Funkhouser, Suzanne U. Emerson, Robert H. Purcell, Eric D'Hondt
  • Hepatitus A virus vaccines
    Publication number: 20020176869
    Abstract: A live hepatitis A virus adapted to growth in MRC-5 cells, which HAV is preferably characterized by suitable attenuation for effective vaccine administration to humans and animals without inactivation, methods for adapting HAV to growth in MRC-5, vaccine compositions and method of vaccinating humans against HAV infection.
    Type: Application
    Filed: April 29, 2002
    Publication date: November 28, 2002
    Inventors: Ann W. Funkhouser, Suzanne U. Emerson, Robert H. Purcell, Eric D'Hondt
  • Hepatitis A virus vaccines
    Patent number: 6423318
    Abstract: A live hepatitis A virus adapted to growth in MRC-5 cells, which HAV is preferably characterized by suitable attenuation for effective vaccine administration to humans and animals without inactivation, methods for adapting HAV to growth in MRC-5, vaccine compositions and method of vaccinating humans against HAV infection.
    Type: Grant
    Filed: August 31, 2000
    Date of Patent: July 23, 2002
    Assignees: The United States of America as represented by the Department of Health and Human Services, SmithKline Beecham Biologicals
    Inventors: Ann W. Funkhouser, Suzanne U. Emerson, Robert H. Purcell, Eric D'Hondt
  • Attenuated hepatitis a virus vaccine which grows in MRC-5 cells
    Patent number: 6180110
    Abstract: A live hepatitis A virus (HAV) adapted to grow in MRC-5 cells is described, the HAV preferably characterized by suitable attenuation for effective vaccine administration to humans and animals without inactivation. Methods for adapting HAV to grow in MRC-5 cells, vaccine compositions comprising the attenuated HAV, and methods of vaccinating humans against HAV infection are also described.
    Type: Grant
    Filed: April 17, 1995
    Date of Patent: January 30, 2001
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Ann W. Funkhouser, Suzanne U. Emerson, Robert H. Purcell, Eric D'Hondt
  • Hepatitis A virus vaccines
    Patent number: 6113912
    Abstract: A live hepatitis A virus adapted to growth in MRC-5 cells, which HAV is preferably characterized by suitable attenuation for effective vaccine administration to humans and animals without inactivation, methods for adapting HAV to growth in MRC-5, vaccine compositions and method of vaccinating humans against HAV infection.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 5, 2000
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Ann W. Funkhouser, Suzanne U. Emerson, Robert H. Purcell, Eric D'Hondt